Mr. Speaker, as I have said over and over again, my Health Canada officials are gathering the facts in relation to the contracting question. I expect to have that factual record presented to me in very short order.
Lost her last election, in 2006, with 39% of the vote.
Government Contracts March 20th, 2003
Mr. Speaker, as I have said over and over again, my Health Canada officials are gathering the facts in relation to the contracting question. I expect to have that factual record presented to me in very short order.
Health March 20th, 2003
Mr. Speaker, such emergencies begin at the local level. Health Canada works to ensure that all levels of government are prepared to respond in a coordinated fashion to local health emergencies and outbreaks of disease. In fact, since September 11, 2001, we have spent about $90 million to boost our capacity on the ground across the country.
There are now national contingency plans for specific illnesses, such as influenza or smallpox. Our surveillance system picks up information about local risks, and our centres for emergency preparedness and disease prevention work with provincial authorities to respond. Finally, Health Canada laboratories and scientists provide expertise and advice to provincial authorities to identify specific risks.
Government Contracts March 19th, 2003
Mr. Speaker, let me give a simple answer, and an answer that I have given before in the House, which is very simply that my officials are gathering the necessary facts around the administration of the contract in question. I look forward to receiving those details.
Government Contracts March 19th, 2003
Mr. Speaker, let me be clear. I have been advised that no one is questioning the quality of the work done. As I have said before in response to the hon. member's questions, Health Canada officials are gathering the facts in relation to the contract in question. I look forward to receiving those facts when that work is finished.
Health March 18th, 2003
In fact, Mr. Speaker, the issue of fully informed consent as it relates to clinical trials is a very important one and one that is largely within the jurisdiction of the provinces and territories to ensure, but clearly the hon. member does raise a very serious question, and one which my officials are working with their provincial and territorial colleagues in relation to, to ensure that nothing but the highest standards are in fact in place and observed as related to clinical trials.
Health March 18th, 2003
Mr. Speaker, this is obviously a serious public health concern. We, at this moment, have 11 confirmed or suspected cases, and that includes, unfortunately, two deaths. We are employing our state-of-the-art laboratories as well as our national surveillance system to monitor the situation.
I think, as the hon. member is aware, there is very little known about this disease at this time. My officials are working with officials around the world to try and learn more about the nature and cause of this disease. We are also working very closely with our provincial and territorial public health colleagues--
Government Contracts March 18th, 2003
Mr. Speaker, I am not aware of any contract that my department had with this named individual in February 2002. To honour a commitment made as part of her existing contract, the contractor, Joanne Meyer, was permitted to participate in and attend a meeting on suicide prevention last January 2002. The contractor was paid approximately $1,000.
As I indicated yesterday, my department is reviewing the facts of this matter. If the hon. member has facts that could help in this--
Question No. 114 March 17th, 2003
The information contained in the tobacco products information regulations represents the official view of the government. In fact, section 42.1(1) of the Tobacco Act requires that all proposed regulations must first be laid before the House of Commons.
Subsection 3(2) of the tobacco products information regulations includes the health warning messages and health information messages contained in the health warnings and information for tobacco products.
The health warning messages help ensure that Canadians are much better informed about the many serious health hazards associated with tobacco products. The regulations also require that smokers receive cessation information or information on tobacco-related diseases on the inside of the tobacco package.
The current labels are the result of approximately two years of intensive study and evaluation. Each health warning and health information message has been reviewed and approved by a scientific panel.
Question No. 104 March 17th, 2003
(a) The government is not offering financial compensation to victims of alleged faulty breast implants.
(b) Results from this study will be released as soon as possible following the analysis of the data.
(c) The study in question was very large and complicated, involving many different organizations. It took approximately four years to reach the stage where the provinces, Ontario and Quebec, had collected the data and assembled the cohort required. This data was submitted to Statistics Canada for approval of the cohort/mortality/cancer incidence linkage process. In August 2002, Statistics Canada released the linked data to Ontario and Quebec so that the cancer staging information could be added to the linked records.
The analysis team, involving representatives from Ontario, Quebec and Health Canada, met on February 17, 2003. An analysis plan was drawn up and agreed to by all parties. A report will be prepared for public release following the completion of the data analysis.
(d) Health Canada is assessing the feasibility of a national breast implant registry.
(e) Health care costs are tracked by the provincial ministries.
(f) No.
(g) Breast implants are medical devices and must meet the requirements of the Food and Drugs Act and the medical devices regulations before being offered for sale. Under this act and the regulations, the responsibility of selling safe and effective medical devices resides with the manufacturer. Breast implants have been placed in the highest risk class of medical devices. These devices undergo the highest degree of premarket review prior to sale.
No medical device sold in Canada is without risk. The degree of remaining risk for any medical device must be balanced with potential benefit for the patient. The discussion of risk and benefit for any medical treatment is held between patients and their health care provider. The decision is made by the patient in consultation with her physician. Physicians are urged by their professional associations to obtain a signed informed consent before treatment.
(h) The sale of a medical device under part 2 of the regulations, i.e. special access, requires health care professionals to sign a declaration that they have provided the patient with details of the risks and potential benefits of the device. Physicians must also inform patients that the device is being obtained under the special access program.
For each patient receiving a saline or silicone gel-filled breast implant or tissue expander through the special access program, Health Canada has a signed attestation from surgeons involved, as required by section 71(1) of the Medical Devices Regulations, that they have informed the patient of the risks and benefits associated with the device to be used.
Health Canada has requested, obtained and reviewed basic safety data from manufacturers whose breast implants are requested by health care professionals through the special access program.
(i) The department has investigated the potential risks brought to its attention, requesting and evaluating additional information regarding breast implants from their manufacturers. Independent studies and research were conducted into these potential risks and several internal and external advisory committees were struck to investigate the concerns.
A voluntary moratorium on the sale of silicone gel-filled breast implants was put in place in 1992. In 1993 the then Minister of Health announced that these devices could not be sold in Canada until manufacturers were able to address the outstanding safety and effectiveness concerns.
Health Canada has increased the amount of information provided by the manufacturers, through their product monographs, to women considering breast surgery. Additional information has also been provided to Canadian women via the “It’s Your Health” publications discussing breast implants and medical devices in general.
Government Contracts March 17th, 2003
Mr. Speaker, as I have already indicated, my department is looking into this matter. I obviously await its report in relation to this contractual situation.
I can only underscore again for the hon. member that the named individual involved is no longer employed by the Department of Health.